By Jan K. Seigel | Published December 3, 2012 | Posted in Pharmaceutical Injuries | Tagged Tags: dangerous drugs, defective product, pharmaceutical companies | Leave a comment
The Food and Drug Administration (FDA) recently announced a recall involving atorvastatin, the generic version of the popular cholesterol reducing drug, Lipitor. According to a number of news reports, the drug was being recalled after some pills contained glass particles. The drug’s maker, Ranbaxy announced that it will stop producing atorvastatin while it completes an Read More
Read MoreWe place our trust in doctors, assuming that they will make decisions based on the best interests of patients rather than the financial interests of pharmaceutical companies. A recent report released by ProPublica has many questioning the validity of this assumption, however. According to this report, pharmaceutical companies routinely pay doctors for speaking about their Read More
Read More